9 nuovi farmaci in commercio

Italia

Nuove specialitÓ medicinali: Carelimus, Takrozem.5 Nuovi farmaci equivalenti

Nuove specialità medicinali
CARELIMUS unguento 0,1% 10 g tacrolimus monoidrato
DIFA COOPER AIC:043815048 9,24€ A/RRL in commercio dal:10/04/2020

CARELIMUS unguento 0,1% 30 g tacrolimus monoidrato
DIFA COOPER AIC:043815051 27,71€ A/RRL in commercio dal:10/04/2020

TAKROZEM unguento 0,1% 10 g tacrolimus monoidrato
PIERRE FABRE AIC:044064044 9,24€ A/RRL in commercio dal:01/04/2020

TAKROZEM unguento 0,1% 30 g tacrolimus monoidrato
PIERRE FABRE AIC:044064057 27,71€ A/RRL in commercio dal:01/04/2020

Nuovi farmaci equivalenti
AMOXICILLINA ACIDO CLAVULANICO ZENTIVA ITALIA 12 cpr riv 875 mg + 125 mg amoxicillina triidrato/potassio clavulanato
ZENTIVA AIC:044262018 7,90€ A/RR in commercio dal:25/03/2020

ERLOTINIB MYLAN 30 cpr riv 100 mg erlotinib cloridrato
MYLAN AIC:044995013 1.726,61€ H/RNRL in commercio dal:23/03/2020

ERLOTINIB MYLAN 30 cpr riv 150 mg erlotinib cloridrato
MYLAN AIC:044995037 2.154,10€ H/RNRL in commercio dal:24/03/2020

VINORELBINA DOC 1 cps 20 mg vinorelbina bitartrato
DOC AIC:046717017 37,78€ A/RNRL in commercio dal:30/03/2020

VINORELBINA DOC 1 cps 30 mg vinorelbina bitartrato
DOC AIC:046717031 56,67€ A/RNRL in commercio dal:30/03/2020